Apexigen Financials
APGNWDelisted Stock | USD 0.02 0.0001 0.66% |
Apexigen |
Understanding current and past Apexigen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Apexigen's financial statements are interrelated, with each one affecting the others. For example, an increase in Apexigen's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Apexigen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Apexigen. Check Apexigen's Beneish M Score to see the likelihood of Apexigen's management manipulating its earnings.
Apexigen Stock Summary
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. The company was founded in 2010 and is based in San Carlos, California. Apexigen Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
Business Address | 75 Shoreway Road, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.apexigen.com |
Phone | 650 931 6236 |
Currency | USD - US Dollar |
Apexigen Key Financial Ratios
Apexigen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apexigen's current stock value. Our valuation model uses many indicators to compare Apexigen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apexigen competition to find correlations between indicators driving Apexigen's intrinsic value. More Info.Apexigen is rated fifth in number of shares shorted category among its peers. It is rated third in ebitda category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Apexigen by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Apexigen Market Pulse
Quote | 0.0153 |
Change(%) | 0.66 |
Change | 0.0001 |
Open | 0.0152 |
Low | 0.0152 |
High | 0.02 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Apexigen is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Apexigen has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Apexigen's financials are consistent with your investment objective using the following steps:- Review Apexigen's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Apexigen's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Apexigen's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Apexigen's stock is overvalued or undervalued.
Apexigen November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Apexigen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Apexigen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Apexigen based on widely used predictive technical indicators. In general, we focus on analyzing Apexigen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Apexigen's daily price indicators and compare them against related drivers.
Information Ratio | (0.04) | |||
Maximum Drawdown | 89.35 | |||
Value At Risk | (28.57) | |||
Potential Upside | 28.57 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |